NEW YORK (GenomeWeb) – Following the successful closing of its tender offer for a majority stake in Foundation Medicine, Roche today provided an update on how it intends to collaborate with the firm for its clinical drug development. Roche also provided an update on its other next-generation sequencing-based investments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.